Ethiopia Sterile Injectable Line: Project Guide (2026)
ShieldVax's $70M Kilinto vaccine plant is Ethiopia's first sterile fill-finish build. How the project gets specified, financed, and built end to end.
September 2026 8 min read
ShieldVax's $70M Kilinto vaccine plant is Ethiopia's first sterile fill-finish build. How the project gets specified, financed, and built end to end.
Zambia's first injectable line is rising at Lusaka South MFEZ behind a USD 50M government offtake deal, commercial output targeted 2028.
No injectable filling line is built in Uganda. Where used and modular sterile lines come from, what an 11,500 m2 BFS incumbent means, and landed cost.
France runs 271 pharma plants and is Europe's #2 in biomedicines. Inside the French fill-finish CDMO field and how to reach drug-product buyers.
The vaccine contract manufacturing market hits USD 5.24B in 2026. How Swiss fill-finish CDMOs win biologics and vaccine drug-product mandates.
Ghana imports 99% of its vaccines and is building local fill-finish lines for 600 million doses a year. Here is who buys the kit and how to reach them.
Used and modular sterile fill-finish lines into South Africa: 5 sourcing channels, the GMP requalification workflow, and freight realities for buyers.
What a sterile injectable filling line costs in Nigeria: line scope, isolator vs RABS, the lyophilizer add-on, and cleanroom and qualification budget.